Intensification to triple therapy non-biologic disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States from 2009 to 2014

OBJECTIVE: Several trials suggest that triple therapy (methotrexate, sulfasalazine, and hydroxychloroquine) and biologic disease-modifying antirheumatic drugs (bDMARD) have similar efficacy in rheumatoid arthritis (RA). We investigated intensification to triple therapy after initial non-biologic (nb...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Rheumatol
Autors principals: Sparks, Jeffrey A., Krumme, Alexis A., Shrank, William H., Matlin, Olga S., Brill, Gregory, Pezalla, Edmund J., Choudhry, Niteesh K., Solomon, Daniel H.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5068482/
https://ncbi.nlm.nih.gov/pubmed/26866506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39617
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars